T1 squamous cell carcinoma of the arytenoid
| Autor: | Gregory S. Weinstein, Henri Laccourreye, E. Chabardes, Ollivier Laccourreye, Martin Housset, Daniel Brasnu |
|---|---|
| Rok vydání: | 1992 |
| Předmět: |
Larynx
Adult Male medicine.medical_specialty medicine.medical_treatment Laryngectomy Radiotherapy High-Energy Antineoplastic Combined Chemotherapy Protocols otorhinolaryngologic diseases Sore throat Carcinoma Medicine Humans Cobalt Radioisotopes Laryngeal Neoplasms Cancer staging Aged Neoplasm Staging Aged 80 and over business.industry Arytenoid cartilage Radiotherapy Dosage Middle Aged medicine.disease Surgery Radiation therapy Survival Rate Vitamin B 12 medicine.anatomical_structure Treatment Outcome Otorhinolaryngology Head and Neck Neoplasms Lymphatic Metastasis Carcinoma Squamous Cell Female Fluorouracil medicine.symptom Cisplatin Neoplasm Recurrence Local business Odynophagia Arytenoid Cartilage Follow-Up Studies |
| Zdroj: | The Laryngoscope. 102(8) |
| ISSN: | 0023-852X |
| Popis: | Twenty-two cases of early squamous cell carcinoma of the arytenoid cartilage staged as T1 according to the 1983 American Joint Committee for Cancer Staging Classification system were reviewed. Eighteen percent of the patients showed no symptoms. In the remaining 82%, the main presenting symptom was pain in the form of sore throat, odynophagia, or otalgia. Radiotherapy and partial laryngeal surgery were the options retained for the treatment of the larynx. A "watch and wait" policy or preventive treatment of the ipsilateral jugulocarotid lymph nodes were the treatment options retained for the neck. Significant differences were noted in terms of local and nodal recurrence between the two programs. Results indicate that partial laryngeal surgery with total arytenoidectomy and preventive treatment of the neck appear to be advisable for this particular type of primary lesion. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text